Core Viewpoint - Growth investors are increasingly focused on stocks with above-average financial growth, which can lead to solid returns, but identifying such stocks can be challenging due to their inherent risks and volatility [1] Group 1: Company Overview - MTU Aero Engines AG (MTUAY) is currently highlighted as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 29.6%, with projected EPS growth of 35.1% for the current year, significantly surpassing the industry average of 22.1% [5] - MTU Aero Engines has demonstrated a year-over-year cash flow growth of 34.7%, which is notably higher than the industry average of 16.5% [6] Group 2: Financial Metrics - The annualized cash flow growth rate for MTU Aero Engines over the past 3-5 years stands at 8.6%, compared to the industry average of 2.2% [7] - The current-year earnings estimates for MTU Aero Engines have been revised upward, with the Zacks Consensus Estimate increasing by 0.9% over the past month [8] Group 3: Investment Potential - The combination of a Zacks Rank 1 (Strong Buy) and a Growth Score of B positions MTU Aero Engines favorably for potential outperformance, making it an attractive option for growth investors [9][10]

Core Viewpoint - Growth investors seek stocks with above-average financial growth, but identifying such stocks can be challenging due to associated risks and volatility [1] Group 1: Company Overview - Globus Medical (GMED) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 15.9%, with projected EPS growth of 18.2% this year, surpassing the industry average of 18.1% [5] Group 2: Financial Metrics - Cash flow growth for Globus Medical is currently at 86.1%, significantly higher than the industry average of -2.4% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 32.6%, compared to the industry average of 6.3% [7] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for Globus Medical, with the Zacks Consensus Estimate for the current year increasing by 18% over the past month [8] - The combination of a Zacks Rank 1 and a Growth Score of A positions Globus Medical as a potential outperformer for growth investors [10]

Core Viewpoint - Growth investors are increasingly focused on stocks with above-average financial growth, but identifying such stocks can be challenging due to inherent volatility and risks [1] Group 1: Tapestry's Growth Potential - Tapestry (TPR) is currently recommended as a cutting-edge growth stock due to its favorable Growth Score and top Zacks Rank [2] - The historical EPS growth rate for Tapestry is 21.7%, with projected EPS growth of 10% this year, surpassing the industry average of 8.8% [4] - Tapestry's year-over-year cash flow growth stands at 10.6%, significantly higher than the industry average of -3.2% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 21.2%, compared to the industry average of 7.6% [6] Group 2: Earnings Estimate Revisions - Positive trends in earnings estimate revisions are crucial, with Tapestry's current-year earnings estimates rising by 2.9% over the past month [7] - Tapestry has achieved a Growth Score of A and a Zacks Rank 2, indicating strong potential for outperformance [9]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those with genuine growth prospects can be challenging [1] Group 1: Company Overview - Adtalem Global Education (ATGE) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2][10] Group 2: Earnings Growth - Historical EPS growth rate for Adtalem is 22.4%, with projected EPS growth of 16.6% this year, surpassing the industry average of 12.9% [5] Group 3: Asset Utilization - Adtalem has an asset utilization ratio (sales-to-total-assets) of 0.66, indicating greater efficiency compared to the industry average of 0.65 [6] Group 4: Sales Growth - The company's sales are expected to grow by 7.6% this year, significantly higher than the industry average of 3.7% [7] Group 5: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Adtalem, with a 0.6% increase in the Zacks Consensus Estimate for the current year over the past month [8]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those with true potential can be challenging [1] Group 1: Company Overview - Orla Mining Ltd. (ORLA) is highlighted as a promising growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 79.3%, with projected EPS growth of 185% this year, significantly surpassing the industry average of 67.7% [4] Group 2: Financial Metrics - Orla Mining's year-over-year cash flow growth is 58.9%, well above the industry average of 6% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 49.7%, compared to the industry average of 15.4% [6] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for Orla Mining, with the Zacks Consensus Estimate for the current year increasing by 20.8% over the past month [8] - This upward revision trend contributes to Orla Mining's Zacks Rank of 2 and a Growth Score of A, indicating strong potential for outperformance [10]

Core Viewpoint - Investors are seeking growth stocks that exhibit above-average growth in financials, which can lead to exceptional returns, but identifying such stocks is challenging due to their inherent risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing a company's real growth prospects beyond traditional metrics [2] - Neurocrine Biosciences (NBIX) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth indicating strong prospects [4] - Neurocrine's historical EPS growth rate is 16.2%, but projected EPS growth for this year is expected to be 99%, significantly surpassing the industry average of 24.6% [5] Group 3: Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, allowing them to fund new projects without relying on external financing [6] - Neurocrine's year-over-year cash flow growth is 35.4%, well above the industry average of 3.2% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 39.5%, compared to the industry average of 7.1% [7] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [8] - The current-year earnings estimates for Neurocrine have increased by 16.4% over the past month, indicating a favorable outlook [9] Group 5: Overall Positioning - Neurocrine has achieved a Zacks Rank 1 due to favorable earnings estimate revisions and a Growth Score of B, positioning it well for potential outperformance [11]

Core Viewpoint - Growth investors are increasingly focused on stocks with above-average financial growth, but identifying stocks that can fulfill their growth potential is challenging due to associated risks and volatility [1] Group 1: Company Overview - Hillman Solutions Corp. (HLMN) is identified as a promising growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 24.9%, with projected EPS growth of 18.4% this year, significantly outperforming the industry average of 5.7% [4] Group 2: Financial Metrics - Hillman Solutions Corp. exhibits a year-over-year cash flow growth of 12.5%, surpassing the industry average of 3.1% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 40.2%, compared to the industry average of 10% [6] Group 3: Earnings Estimates - There is a positive trend in earnings estimate revisions for Hillman Solutions Corp., with the current-year earnings estimates increasing by 6.4% over the past month [7] - The company has earned a Growth Score of B and a Zacks Rank 2 due to these positive earnings estimate revisions [9]

Core Viewpoint - Growth investors are increasingly focused on stocks with above-average financial growth, but identifying such stocks can be challenging due to inherent volatility and risks [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - ExlService Holdings (EXLS) is currently highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth indicating strong prospects [3] - ExlService Holdings has a historical EPS growth rate of 20%, with projected EPS growth of 15.4% this year, significantly surpassing the industry average of 8.9% [4] Group 3: Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, allowing them to fund new projects without external financing [5] - ExlService Holdings has a year-over-year cash flow growth of 2.1%, exceeding the industry average of 1.7% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 10.6%, compared to the industry average of 8.6% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [7] - Current-year earnings estimates for ExlService Holdings have been revised upward, with the Zacks Consensus Estimate increasing by 0.1% over the past month [8] Group 5: Overall Positioning - ExlService Holdings has achieved a Growth Score of A and a Zacks Rank of 2 due to positive earnings estimate revisions, positioning it well for potential outperformance [10]

Core Insights - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those with true potential can be challenging [1] - Vital Farms (VITL) is highlighted as a recommended growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly desirable [4] - Vital Farms has a historical EPS growth rate of 92.5%, with projected EPS growth of 17.1% this year, significantly outperforming the industry average of 4.4% [5] Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, allowing them to fund new projects without relying on external financing [6] - Vital Farms currently exhibits a year-over-year cash flow growth of 86.6%, far exceeding the industry average of 4.2% [6] - The company's annualized cash flow growth rate over the past 3-5 years stands at 68.3%, compared to the industry average of 4.6% [7] Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with stock price movements [8] - Vital Farms has seen upward revisions in current-year earnings estimates, with the Zacks Consensus Estimate increasing by 2.4% over the past month [9] Conclusion - Vital Farms holds a Zacks Rank of 2 and a Growth Score of B, positioning it well for potential outperformance in the growth stock category [11]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying the right ones can be challenging due to associated risks and volatility [1] Group 1: Company Overview - Cavco (CVCO) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 20% and is projected to achieve an EPS growth of 20.7% this year, significantly outperforming the industry average of -0.8% [5] Group 2: Financial Metrics - Cavco's year-over-year cash flow growth stands at 12.2%, surpassing the industry average of 0% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 19.6%, compared to the industry average of 8.7% [7] Group 3: Earnings Estimates - The Zacks Consensus Estimate for Cavco's current-year earnings has increased by 3.8% over the past month, indicating a positive trend in earnings estimate revisions [8] - Cavco has earned a Growth Score of B and holds a Zacks Rank 2 due to these positive earnings estimate revisions, positioning it well for potential outperformance [10]